BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30626077)

  • 1. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.
    Kawauchi H; Yanai K; Wang DY; Itahashi K; Okubo K
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abdelshafy AM; Abdallah SY; Hassan AF; Mohamed HA; Kamal NM; Ali ST; Abdelhaleem IA
    Am J Rhinol Allergy; 2022 Sep; 36(5):684-694. PubMed ID: 35593100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines.
    Gillman S; Gillard M; Strolin Benedetti M
    Allergy Asthma Proc; 2009; 30(4):366-76. PubMed ID: 19335943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma.
    Bachert C; Maspero J
    J Asthma; 2011 Nov; 48(9):965-73. PubMed ID: 21970671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of non-sedating antihistamines.
    Yanai K; Yoshikawa T; Yanai A; Nakamura T; Iida T; Leurs R; Tashiro M
    Pharmacol Ther; 2017 Oct; 178():148-156. PubMed ID: 28457804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
    Church MK; Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos NG; Rodriguez Del Rio P;
    Expert Rev Clin Immunol; 2023; 19(7):813-820. PubMed ID: 37191185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilastine as a potential treatment in allergic rhinitis.
    Kowal K; DuBuske L
    Am J Rhinol Allergy; 2014; 28(4):312-6. PubMed ID: 25197918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Antihistamines and their Properties used for Treatment of Different Diseases.
    Chaudhari R; Gosavi S; Bornare P; Sonawane S; Ahire T
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(4):220-229. PubMed ID: 38018180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
    Jáuregui I; Ramaekers JG; Yanai K; Farré M; Redondo E; Valiente R; Labeaga L
    Expert Opin Drug Saf; 2016 Jan; 15(1):89-98. PubMed ID: 26571227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihistamines: ABC for the pediatricians.
    Parisi GF; Licari A; Papale M; Manti S; Salpietro C; Marseglia GL; Leonardi S
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():34-36. PubMed ID: 32017222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation antihistamines in asthma therapy: is there a protective effect?
    Walsh GM
    Am J Respir Med; 2002; 1(1):27-34. PubMed ID: 14720073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihistamine therapy in allergic rhinitis.
    Hoyte FC; Katial RK
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):509-43. PubMed ID: 21737041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihistamines on innate immune responses to severe bacterial infection in mice.
    Metz M; Doyle E; Bindslev-Jensen C; Watanabe T; Zuberbier T; Maurer M
    Int Arch Allergy Immunol; 2011; 155(4):355-60. PubMed ID: 21346365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are second-generation H1-antihistamines minimally sedating?
    Hu Y; Sieck DE; Hsu WH
    Eur J Pharmacol; 2015 Oct; 765():100-6. PubMed ID: 26291661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.